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ABSTRACT
Plus-strand RNA viruses can accumulate viral RNA
degradation products during infections. Some of
these decay intermediates are generated by the cy-
tosolic 5′-to-3′ exoribonuclease Xrn1 (mammals and
yeast) or Xrn4 (plants) and are formed when the en-
zyme stalls on substrate RNAs upon encountering in-
hibitory RNA structures. Many Xrn-generated RNAs
correspond to 3′-terminal segments within the 3′-
UTR of viral genomes and perform important func-
tions during infections. Here we have investigated
a 3′-terminal small viral RNA (svRNA) generated by
Xrn during infections with Tobacco necrosis virus-D
(family Tombusviridae). Our results indicate that (i)
unlike known stalling RNA structures that are com-
pact and modular, the TNV-D structure encompasses
the entire 212 nt of the svRNA and is not function-
ally transposable, (ii) at least two tertiary interac-
tions within the RNA structure are required for ef-
fective Xrn blocking and (iii) most of the svRNA gen-
erated in infections is derived from viral polymerase-
generated subgenomic mRNA1. In vitro and in vivo
analyses allowed for inferences on roles for the
svRNA. Our findings provide a new and distinct ad-
dition to the growing list of Xrn-resistant viral RNAs
and stalling structures found associated with differ-
ent plant and animal RNA viruses.
INTRODUCTION
Viruses face hostile cellular environments during infections
and their genomes represent key targets for cellular nucle-
ases. The genomes of plus-strand RNA viruses are sub-
strates both for endo- and exoribonucleases (1), and one ri-
bonuclease that engages viral RNAs is the cytosolic enzyme
Xrn1 (2). This 5′-to-3′ exoribonuclease plays a major role in
eukaryotic cellularmRNA turnover by convertingmessages
into nucleoside monophosphates (3). Access of Xrn1 to the
5′-end of mRNAs requires prior removal of the cap struc-
ture, which creates RNAs with 5′-monophosphates, the fa-
vored substrate for Xrn1 (4). This exonuclease is highly pro-
cessive, however G-rich tracts and some RNA structures
can impede its progress (5).
Xrn1 is a restriction factor for some plus-strand RNA
viruses (6,7), however, in some cases, its activity is beneficial
to infections (8,9). An example of this latter role comes from
flaviviruses where, during infections, fragments that are 3′-
coterminal with their plus-strand RNA genomes, termed
subgenomic flavivirus RNAs (sfRNAs), are generated by
Xrn1 (10). The fragments that accumulate have well defined
5′-termini and correspond to segments of the 3′-UTRs of
flavivirus RNA genomes. SfRNAs have been shown to in-
fluence symptoms and to modulate viral infections in dif-
ferent ways, including inhibiting host Xrn1 exoribonucle-
ase and muting the host immune response (11). The forma-
tion of sfRNAs relies on the presence of RNA sequences
which form higher-order RNA structures that cause Xrn1
to stall (12–14). Notably, the atomic structures of the
stalling RNAs in two flaviviruses, Murray Valley encephali-
tis virus and Zika virus, have been solved (15,16). These
structures revealed similar complex folds which formRNA-
based braces that block Xrn1 progression. Additional anal-
yses revealed that these structures also stall other 5′-to-3′ ex-
onucleases, suggesting a general barrier-based mechanism
for hindering nucleasemovement (17). This phenomenon of
Xrn1 stalling and generating distinct virally-derived 5′-ends
extends beyond flaviviruses. Xrn1-resistant RNAs have also
been identified in other mammalian RNA viruses such as
Hepatitis C virus and Bovine viral diarrhea virus (18), as
well as phleboviruses and arenaviruses (19). However, the
structural nature of the RNA elements responsible for these
stalling events remains undetermined.
In plants, cytosolic Xrn4 is the functional equivalent of
Xrn1 (20) and can either restrict (6,21) or facilitate infec-
tions (8). Similar to flaviviruses, small virally-derived 3′-
terminal fragments from different plus-strand RNA plant
viruses have been reported (22) and those associated with
luteoviruses are among the earliest described (23–25). The
origin of these luteovirus small RNAs is currently un-
known, but they may be products of Xrn4 activity dur-
ing plant infections. There are, however, two plant viruses,
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Beet necrotic yellow vein virus (BNYVV; genus Benyvirus,
family Benyviridae) and Red clover necrotic mosaic virus
(RCNMV; genus Dianthovirus, family Tombusviridae), for
which generation of Xrn-resistant RNAs have been con-
firmed. Non-coding RNA3 (ncRNA3), is derived from
genome segment RNA3 of BNYVV and is required for
long-distance movement of infections in plants (26,27).
NcRNA3 production in vitro by recombinant Xrn1 involves
a 43 nt segment that forms two hairpin structures separated
by a spacer sequence (28). In RCNMV, the RNA1-derived
fragment that accumulates is termed SR1f, and it facili-
tates plant infections, possibly by regulating viral transla-
tion, replication, or packaging (29). For RCNMV, a 43 nt
long sequence is also needed for Xrn1 stalling, but its se-
quence is distinct from that in BNYVV (30). The crystal
structure of the RCNMV stall signal inferred an RNA fold
that could act as a brace against Xrn4, however, its confor-
mation is distinct from those found in flaviviruses (30).
In addition to RCNMV, small 3′-terminal, genome-
derived, RNAs have been reported for othermembers of the
family Tombusviridae, but they have not been characterized
(31–34). This group includes Tobacco necrosis virus-D in
the genus Betanecrovirus, which has a ∼3.8 kb plus-strand
RNA genome that is packaged into an icosahedral parti-
cle (35). The genome is neither 5′-capped nor 3′-poly(A)
tailed and encodes five open reading frames (ORFs) (Fig-
ure 1A). Upon infection, the accessory replication pro-
tein (p22) and its readthrough product (p88), the RNA-
dependent RNA polymerase, are translated directly from
the genome (36,37). Translation is mediated by an RNA
structure in the 3′-untranslated region (3′-UTR) termed
the 3′ cap-independent translational enhancer (3′-CITE),
which functions by binding to eukaryotic initiation factor
4G (eIF4G) (38,39). The 3′-CITE also supports translation
of two subgenomic (sg) mRNAs that are transcribed during
infections (32). Two small proteins that mediate virus move-
ment within the plant, p7a and p7b, are expressed from the
larger sg mRNA1, while the viral capsid protein (CP) is
translated from sg mRNA2 (40) (Figure 1A).
Here, a 3′-terminal small viral RNA (svRNA) associated
with TNV-D infections was investigated. The results indi-
cate that it is generated by Xrn4 digestion and that a com-
plex RNA structure is involved in the stalling event leading
to its formation. Possible functions of this svRNA are in-
vestigated and discussed.
MATERIALS AND METHODS
TNV-D constructs
The full-length infectious TNV-D clone (GenBank
D00942.1) has been reported previously (35), and all
mutants were derived from this construct. The TNV-D sg
mRNA1 (initiating at genome coordinate 2216) and sg
mRNA2 (coordinate 2557) clones were generated as de-
scribed previously (40). Standard overlapping PCR-based
mutagenesis was used to introduce mutations into the
genomic or subgenomic RNA clones of TNV-D. All clones
were sequenced to ensure the presence of only the intended
modifications.
In vitro transcription and viral RNAs
All RNA transcripts were generated by in vitro transcrip-
tion of either SmaI-linearized clones or 3′-ends that were
delineated by PCR-products, as described previously using
a T7-FlashScribe transcription kit (41). Capped luciferase
and wasabi mRNAs were transcribed from linearized ex-
pression vector using an AmpliCap-Max T7 Transcription
Kit. Transcript integrity was verified by agarose gel elec-
trophoresis prior to use. Transcript 50-svRNA, included the
fifty contiguous viral nucleotides 5′-proximal to the primary
Xrn termination site and was used for in-line probing and
Xrn1 inhibition assays.
Protoplast infections and northern blot analysis
Protoplasts were isolated from 6- to 7-day-old cucumber
cotyledons as described previously (42). Following isola-
tion, 3 × 105 protoplasts were transfected with 5 g of ge-
nomic TNV-D transcripts, mediated by PEG-CaCl2. Trans-
fected protoplasts were incubated under constant light for
22 h at 22◦C. Total nucleic acids were phenol extracted and
ethanol precipitated, after which one-sixth of the prepa-
ration was separated in 2% agarose gels and transferred
to nylon membrane. Northern blot analysis was carried
out using two internally-labeled 32P-labeled DNA oligonu-
cleotide probes that were complementary to two different
regions of the 3′-UTR of TNV-D that did not overlap with
regions containing nucleotide substitutions in mutants: GA
CTGGGTTCCTAGAGAGATCTCTAGGTAAATAAAG
AGGGGAC-3′(−), complementary to the 3′-terminal 39
nts of the viral genome (coordinates 3725–3763, under-
lined), and GTGATACGACGGCCCACCACCACAGT
GAGCCCGTTAAACCTGTTTCCCAGGATCC-3′(−)
complementary to the apical sequence of the BTE structure
(coordinates 3592–3646). Both probes were used for all
northern blot analyses, except for the BTE truncation
mutants, where only the 3′-terminal probe was used (due
to overlap between the BTE deletions and the BTE-
targeted probe) (36). Probes were generated using Klenow
fragment (NEB Cat# M0210L) using primer/template
pairs. 3′-Terminal probe: template (+)5′-GTCCCCTCTT
TATTTACCTAGAGATCTCTCTAGGAACCCAGTC
and primer (−)5′-GACTGGGT. BTE-targeted probe:
template: (+)5′-GGATCCTGGGAAACAGGTTTAACG
GGCTCACTGTGGTGGTGGGCCGTCGTATCAC
and primer (−)5′-GTGATACG). Probes were synthesized
using 5 U of Klenow fragment in the presence of [-32P]-
dATP and unlabeled CTP, GTP and TTP for 1 h at 25◦C.
Labeling reactions were stopped using 20 mM EDTA
and purified via G50 sephadex columns. All protoplast
infection experiments were repeated three times.
In vitro Xrn1 digestion assay
Purified Xrn1 from Saccharomyces cerevisiae was obtained
from New England Biolabs (NEB) (Cat# M0338L). Buffer
conditions for reactions were followed as described pre-
viously (14). Briefly, 2 g of wild-type (wt) or mutant sg
mRNA1 were incubated in 1× EC3 buffer (100 mM NaCl,
10 mM MgCl2, 50 mM Tris, pH 7.9, 1 mM DTT) with 0.5
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Figure 1. TNV-D genome and identification of svRNA. (A) Schematic representation of the TNV-D genome with encoded proteins shown as rectangles.
The initiation sites of the two subgenomic (sg) mRNAs are marked below by arrows. Positions of the 3′-cap-independent translation enhancer (3′-CITE)
and the complementary proximal and distal readthrough elements (PRTE and DRTE, respectively) are also shown. (B) Northern blot of TNV-D infection
in plant protoplasts. Total RNA was separated in 2% agarose gels, transferred to nylon membrane and hybridized with 32P-labelled oligonucleotides
complementary to different 3′-regions of the TNV-D genome. The positions of genomic (g), subgenomic (sg) and small viral (sv) RNAs in the blots are
identified to the left. The position and sizes of relevant RNAs are also shown. (C) Northern blot delineating the approximate 5′-end of the svRNA. The
relative genomic positions of the probes (P1 to P4) are shown along with their corresponding genome coordinates.
U Xrn1 and 4 U RppH (derived from Escherichia coli, ob-
tained from NEB, Cat# M0356S) in the presence of 20 U
RNase inhibitor in a volume of 23 l at 37◦C for 30 min.
RNA was ethanol precipitated with 20 mg glycogen and
0.2 M ammonium acetate, and dissolved in RNase-free wa-
ter. Two-fifths of the RNAs recovered was separated in 2%
agarose gels and transferred to nylon membrane for north-
ern blot analysis. The signal strengths from bands were
quantified using QuantityOne software. All assays were re-
peated three times. The level of resistant svRNA was calcu-
lated as a ratio: i.e. the level of resistant RNA divided by the
level of untreated precursor, which was set as 100%. Repre-
sentative northern blots used for quantification of svRNAs
in Figures 3D and 4A are provided in Supplemental Mate-
rial.
5′-RACE
RNAs extracted from TNV-infected protoplasts or gen-
erated by digestion with Xrn1 in vitro were separated in
2% agarose gels. Bands corresponding to the svRNA were
excised as gel slices and the extracted RNA was ligated
to an oligonucleotide adaptor sequence containing an
SbfI site (bold): 5′-GATCTGCAGCTTGAGCCTGCA
GGGTGCTGCGCAGAGTTCTACAGTCCGAC using
T4 RNA ligase (NEB). RT-PCR was carried out using a
reverse primer complementary to the genome 3′-terminus
(underlined) and containing a SalI site (bold), 5′-GCAGCA
CGTCGACGGGTTCCTAGAGAGATCTCTAGG, and
nested primer 5′-GCAGCTTGAGCCTGCAGGGTGC.
PCR products were double-digested with SbfI and SalI
and ligated into a pUC19 vector, cloned into E. coli, and
individual clones were sequenced.
In-line probing
Wt and mutant 50-svRNAs were transcribed in vitro. Fol-
lowing 5′-end-labeling using [ -32P]-ATP, RNAs were incu-
bated for∼40 h at 25◦C and then separated in 10% sequenc-
ing gels (43). The signal strengths from bands in each lane
were quantified usingQuantityOne software and plotted to-
gether.
In vitro translation competition assay
Uncapped wt TNV-D genomic (0.1 pmol), sg mRNA (0.2
pmol), capped reporter luciferase mRNA or wasabi mRNA
(0.2 pmol) (Luciferase-pcDNA3, pTcI-Wasabi, obtained
from Addgene) were incubated with increasing molar
excesses (1:1 ratio up to 1:64) of uncapped wt svRNA or a
size-matched uncappedRNAcontrol, derived frompUC19,
5′-CUGGCGAAAGGGGGAUGUGCUGCAAGGCGA
UUAAGUUGGGUAACGCCAGGGUUUUCCCAG
UCACGACGUUGUAAAACGACGGCCAGUGAA
UUCGAGCUCGGUACCCGGGGAUCCUCUAGA
GUCGACCUGCAGGCAUGCAAGCUUGGCGUAAU
CAUGGUCAUAGCUGUUUCCUGUGUGAAAUU
GUUAUCCGCUCACAAUUCCACACAACAUAC, in
a wheat germ extract translation system (Promega) (36).
Reactions of 20 l included 10 l wheat germ extract and
were incubated at 25◦C for 2 h.
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In vitro Xrn1 inhibition assay
A Xrn1-sensitive, 50 nt long, non-viral reporter RNA
(Rep) 5′-GGAACAGACAGACAUACAGACGCAGA
CACACACACACACACACACACACA, was used
to assess the protective effect of (i) wt 50-svRNA, (ii)
a mutant 50-svRNA (50-S6C) or, (iii) a size-matched,
non-viral RNA sequence (NS) derived from pUC19 (i.e.
the size-matched sequence provided in previous section
plus the following 50 nt sequence added to its 5′-end:
GAGCCGGAAGCAUAAAGUGUAAAGCCUGGG
GUGCCUAAUGAGUGAGCUAA). Rep and competi-
tor RNAs were in vitro transcribed with a 10-fold molar
excess of GMP over GTP to generate transcripts with
5′-monophosphates, thereby obviating the need to add
RppH, which could potentially be rate limiting for Xrn1
activity. Mixtures of the Rep RNA (3 ng) and each of
the competitor RNAs [(i), (ii) or (iii); 1 g each] were
incubated for 1 min in the absence or presence of 1 U Xrn1
at 37◦C. Upon completion of the reactions, RNA was
phenol extracted, ethanol precipitated, separated in a 2%
agarose gel, transferred to nylon membrane, and probed
for Rep RNA.
Whole plant infections and particle isolation
Three week old Nicotiana benthamiana plants were rub-
inoculated with transcripts of either wt or mutant genomic
TNV-D RNAs as described previously (44). Plants were in-
cubated at 23◦C with a 14 h/10 h day/night cycle until de-
veloping visible symptoms (∼6 days). Three plants were in-
oculated for each viral construct per experiment, and each
experiment was repeated three times. RNA was extracted
from symptomatic inoculated or upper leaves and analyzed
by northern blotting. For virion preparations, plants were
inoculated and incubated as described above. Virus parti-
cles were prepared from systemically-infected leaf tissue via
PEGprecipitation (45) andRNAs extracted from virus par-
ticles were analyzed by northern blotting as described ear-
lier.
RESULTS
TNV-D infections contain a 3′-terminal small viral RNA
Infections of cucumber protoplasts with wt TNV-D were
examined for the accumulation of viral RNAs using a probe
complementary to the very 3′-terminus of the viral genome.
Northern blot analysis revealed that, in addition to the ex-
pected genome and two sg mRNAs, a small viral RNA
(svRNA) was detected consistently (Figure 1B). To assess
how much sequence from the 3′-terminus was present in
the svRNA, additional oligonucleotide probes were utilized
that spanned more upstream regions of the 3′-UTR and
extended into the adjacent p29 capsid-coding region. This
analysis indicated that the 5′-end of the svRNAmapped be-
tween oligos-3 and -2, with the intervening sequence cor-
responding to genome coordinates 3528–3569 (Figure 1C).
Based on these results, the size of the svRNAwas estimated
to be between 195 and 235 nt in length, a size consistent
with its high mobility in agarose gels.
The svRNA is analogous to the products of Xrn1-digested
TNV-D RNAs
The presence of Xrn1-generated 3′-terminal fragments in
other plus-strand RNA virus infections prompted us to in-
vestigate the same possibility for the TNV-D svRNA. Ac-
cordingly, in vitro transcripts of TNV-D genomic and sg
mRNAs were individually subjected to recombinant yeast
Xrn1 in the presence of pyrophosphohydrolase RppH,
which converts 5′-triphosphates in the transcripts to 5′-
monophosphates (14). In this assay, all three viral species
that were subjected to Xrn1 and RppH yielded an RNA
product that comigrated to the same position as the svRNA
generated in protoplast infections (Figure 2A, middle and
right sections). When the 5′-termini of Xrn1-generated
RNAs and in vivo-generated svRNA were cloned and se-
quenced by 5′-RACE (Figure 2B), the most frequent posi-
tions mapped to two adjacent nucleotides located just 5′-
proximal to the basal stem structure of the 3′-CITE; cor-
responding to genomic coordinates 3552 and 3553 (Fig-
ure 2C, green asterisks). 5′-termini at these positions would
yield svRNAs of lengths 211 and 212 nts, which are within
with the size range estimate of 195–235 nt determined by
oligonucleotide probing (Figure 1C). This equivalence in gel
mobility and 5′-termini location between in vitro-generated
small RNAs and in vivo-generated svRNAs is consistent
with the latter being produced by plant Xrn4, the counter-
part to yeast Xrn1 (28). These results also indicate that no
trans-acting cellular or viral proteins are required for this
process to occur.
svRNAs are derived primarily from sg mRNA1
In flaviviruses, which do not produce traditional protein-
coding sg mRNAs, the lone source of Xrn-resistant RNAs
is the viral genome. However, for TNV-D, which synthesizes
two sg mRNAs during infections, either or both messages
could contribute to production of svRNAs in infections.
To examine this possibility, genomic mutants were assessed
that were deficient in transcription of either sg mRNA1 or
sg mRNA2, due to point mutations in their initiating nu-
cleotides (Figure 2D). Inhibition of sg mRNA1 transcrip-
tion resulted in a large decrease in svRNA accumulation in
protoplasts, while inactivation of sg mRNA2 had nominal
effects. Accordingly, most of the svRNA that accumulates
during infections is derived from sg mRNA1.
Structural and functional features of the svRNA
The 3′-region of the TNV-D genome has been well charac-
terized, both structurally and functionally. ThemajorXrn1-
resistant fragment corresponds to a 212 nt long 3′-terminal
segment that contains several functional subregions (Fig-
ure 2C). At the 5′-end is the 3′-CITE, which is composed
of an extended stem structure topped by two stem-loops
(SLs) (38,39,46). Just downstream from the 3′-CITE are
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Figure 2. Comparison of in vitro and in vivo-generated svRNAs. (A) Northern blot comparing in vitro-derived svRNA produced by Xrn1 and svRNAs
produced in protoplast infections. Treatment of viral RNA transcripts with (+) or without (−) RppH and Xrn1 are indicated above the lanes. All sections
shown are from the same gel. (B) 5′-RACE analysis of svRNAs produced by Xrn1 (in vitro) and svRNAs produced in protoplast infections (in vivo).
5′-terminal sequences are shown with their corresponding frequency of occurrence. The dotted box encloses minor stall sites with 5′-ends that originate
further downstream than the other sequences shown and are not aligned with those sequences above. (C) Secondary structure of the 3′-UTR of TNV-D.
Substructures, including SLI, SLII and the 3′-CITE are indicated. Colour-coded asterisks correspond to 5′ nucleotide positions from sequence termini
shown in (B). The major svRNA species (i.e. 211–212) is indicated below the structure. Complementary nucleotides in SLII and the 3′-terminus that
functionally base pair are circled. (D) Northern blot analysis of protoplast infections of TNV-D genomes with inactivated sg mRNA1 (sg1) or sg mRNA2
(sg1) promoters. The lower panel labelled svRNA* is a longer exposure of the svRNA-containing portion of the blot above.
two hairpins, SLII and SLI. Both stem loops are critical
for genome replication, as is a base pairing interaction be-
tween the 3′-terminal four nucleotides and an internal bulge
in SLII (Figure 2C, circled nucleotides) (37). These two hair-
pins flank a 6 nt long sequence, the distal readthrough ele-
ment (DRTE), which can base pair with a complementary
proximal RTE (PRTE) that is present in an RNA structure
3′-adjacent to the p22 stop codon. This RNA-RNA inter-
action mediates translational readthrough resulting in pro-
duction of p82 (Figure 1A) (36). The svRNA thus contains
regulatory elements involved in translation initiation, trans-
lational readthrough, and genome replication.
Terminal regions of svRNA contain determinants of Xrn1 re-
sistance
To examine structural features important for svRNA pro-
duction we utilized transcripts of sg mRNA1 as an in
vitro substrate for Xrn1, which, on average, generated 4.3%
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/47/17/9329/5545013 by York U
niversity Libraries user on 18 February 2020
9334 Nucleic Acids Research, 2019, Vol. 47, No. 17
Figure 3. Mutational analysis of the 5′- and 3′-terminal regions of the svRNA in sg mRNA1. (A) Nucleotides were either added (from pUC19) or deleted
from the 3′-end of TNV-D sg mRNA1. The SLII/3′-end interaction important for genome replication is indicated with dotted arrows. Modifications and
the associated mutant names are shown. (B and C) In vitro Xrn1 assay of sg mRNA1 mutants depicted in (A). The substrate and product RNA species
are labelled to the left, and a bar graphs below the blots quantify corresponding svRNA levels from three independent experiments, ±SE. (D) Mutational
analysis of the 5′-terminal region of svRNA in sg mRNA1. Substitutions in each mutant are shown in red along with relative levels of accumulation of
svRNAs (from three independent experiments, ±SE). Stem 7 (S7) of the 3′-CITE is highlighted in yellow. Black arrowheads indicate the primary Xrn1
stall sites.
svRNA (±0.7%, n= 10) from a reactant pool of sg mRNA1
set as 100%. An interesting feature of previously reported
Xrn-blocking viral RNA structures is their modularity,
whereby they are still functional when introduced into new
sequence contexts (14,29). To assess this aspect of func-
tion, the normal 3′-terminus of sg mRNA1 was extended
by one, five, ten, or fifty nucleotides of adjacent plasmid
sequence (Figure 3A). Two other 10 nt 3′-terminal exten-
sions of differing nucleotide order and composition, mu-
tants SEQ1 and SEQ2, were also assessed, in addition to
another mutant, SL2b, containing a deletion of the bulge
in SLII (Figure 3A). Transcripts were also produced that
lacked two or three nucleotides from the 3′-end.When these
viral RNAs were assayed for svRNA production in vitro, all
modifications resulted in greatly decreased levels of svRNA
(Figure 3B and C). Accordingly, small and large indels at
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the 3′-terminus of the substrate RNA have major effects
on its ability to stall Xrn1; as did deletion of the bulge in
SLII, which is the base pairing partner sequence for the 3′-
terminus (Figure 3A).
The 5′-terminus of the primary svRNA corresponds to
the 5′-border of the 3′-CITE. This position would also be
the location of the Xrn1 active site when the enzyme is
stalled, and nearby nucleotide residues and/or RNA struc-
tures are predicted to affect this event. The substitution of
single nucleotides positioned before, within, or after thema-
jor stall sites had varying effects (Figure 3D). Those changes
corresponding to the region in front of (mutants sr1 to sr3)
or at (sr4 and sr5) the stall sites reduced svRNA production
to ∼50–70% that of wt levels, while the majority of those
mappingwithin the closing stem of the 3′-CITE (sr7 to sr15)
had more substantial negative effects (Figure 3D). For ex-
ample, two of the four single substitutions in the left half of
this closing stem (i.e. sr9 and sr12) caused drops in accumu-
lation to 22% and 25% that of wt, with no or low recovery in
corresponding compensatorymutations (Figure 3D).When
combined with the results from analyses of the 3′-terminus,
the data indicate that both ends of the svRNA contribute
notably to Xrn1 stalling.
Internal regions of the svRNA confer Xrn1 resistance
The largest structural component within the svRNA is the
3′-CITE. Based on the results presented in the previous sec-
tion, the closing stem of this structure, S7 (Figure 4A), is im-
portant forXrn1 stalling. To assess the possible involvement
of other parts of the 3′-CITE, truncations were designed in
an sg mRNA1 substrate that progressively removed upper
sections of the structure and replaced them with a termi-
nal ultra-stable cUUCGg tetraloop (47). Deletion of upper
portions in mutantsTop andMidi resulted in reduced lev-
els of svRNA (∼57% and 38% of wt) (Figure 4A, green).
Removal of additional structure in Mini markedly reduced
svRNA accumulation (∼3% of wt), implicating the midsec-
tion of the 3′-CITE as particularly important for stalling.
Next, the structural requirements within the mid and
lower regions of the 3′-CITE were investigated in more de-
tail. Substitutions in stem 4 in mutant series S4 resulted
in moderate effects that supported a role for base pairing,
while those in stem 5 (series S5) had similar effects without
implicating base pairing as being important (Figure 4A).
Compensatory mutation sets in lower stems 6 and 7 in mu-
tant series S6 and S7 yielded major defects in svRNA lev-
els (i.e. down to ∼10%) and restoration of base-pairing did
not recover function. Changes to the asymmetrical loop be-
tween stems 6 and 7 in series IL6, and mismatches between
stems 5 and 6 in series IL5, also notably inhibited activ-
ity (∼17–23% and ∼21–57%, respectively), while perturba-
tion of another helical interruption further up the structure
in mutant GCUC was well tolerated (99%) (Figure 4A).
These results agree with those from internal truncations of
the 3′-CITE and Figure 3C, with all findings implicating the
lower region of the 3′-CITE as most important for Xrn1
stalling activity.
SLII was also investigated for possible involvement with
Xrn1 stalling activities. Compensatory mutational analysis
indicated that base pairing in the lower (m106, m107 and
m108), middle (m135, m136 and m137), and near-upper re-
gions (m132, m133, and m134; and m129, m130 and m131)
of SLII contributed to its function, albeit to differing de-
grees (Figure 4A). Restoration of canonical complementar-
ity in the base pair closing the terminal loop, did not im-
prove svRNAproduction (mutantsm126, m127 andm128).
Also notable, was that any of eight different changes made
in the terminal loop of SLII caused major decreases in
svRNA production (∼14–29% of wt) (Figure 4A). Collec-
tively, the results from examining the internal sections of
the svRNA implicate SLII and the mid/lower part of the
3′-CITE as highly important elements for stalling Xrn1.
Regions within the svRNA that were required for effi-
cient svRNA production, and which appeared to be highly
dependent on sequence specificity, included the lower re-
gion of the 3′-CITE (i.e. stems 6 and 7 and their interven-
ing internal loop) and the upper region of SLII (i.e. its ter-
minal loop region). Accordingly, we examined the struc-
tural consequences of certain modifications in these regions
by in-line probing, a solution structure analysis method
that identifies flexible residues in an RNA by their propen-
sity to undergo spontaneous cleavage (43). The viral RNAs
analyzed were based on 50-svRNA, which, in addition to
the svRNA sequence, contains fifty contiguous viral nu-
cleotides 5′-proximal to the primary Xrn termination site.
Like sg mRNA1, this 50-svRNA is a substrate for Xrn1,
but, because its 5′-end is much closer to the stall site, analy-
sis of reactivity in this region was more feasible. For mutant
m20, which contained an AACA to GAAA substitution of
the SLII terminal loop sequence and exhibited∼29% activ-
ity, spontaneous RNA cleavage was notably increased in the
region of the modified loop (Figure 4B, top trace, red aster-
isk) when compared to the wt control (Figure 4B, bottom
trace). This suggests that these terminal loop residues are
normally inflexible in the wt structure and thus may inter-
act with other residues. Interestingly, the same loop modi-
fication also led to a small, but reproducible, increase in re-
activity in the 5′-half of S6 and the adjacent asymmetrical
internal loop region of the 3′-CITE (Figure 4B, top trace,
green asterisk), when compared to the wt control. This re-
sult implies a structural connection between the SLII ter-
minal loop and the lower half of the extended helix of the
3′-CITE. This notion was further supported by the analyses
of mutants S6C (∼14% activity) and IL6C (∼17% activity),
containing perturbations in the S6 and adjacent asymmet-
rical internal loop region of the 3′-CITE (Figure 4B, sec-
ond and third traces, red asterisks), which induced promi-
nent cleavages in the SLII loop region (Figure 4B, second
and third traces, green asterisks). In contrast, mutant sr10
(∼14% activity) at the base of the 3′-CITE did not cause
notable cleavage in the SLII loop or elsewhere. The coupled
structural effects observed for mutants m20, S6C and IL6C
suggest that the loop of SLII needs to interact with the lower
region of the 3′-CITE to form an effective blocking struc-
ture.
Comparison of Xrn1 sensitivity in vitro with svRNA accumu-
lation in virus infections
To assess how closely in vitro results reflected those from in
vivo studies, several mutations that were assayed for Xrn1
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Figure 4. Mutational analysis of internal regions of the svRNA in sg mRNA1 and RNA structural analysis of selected 50-svRNA mutants defective at
generating svRNAs. (A) Summary of in vitroXrn1 assays of sg mRNA1mutants containing substitutions or deletions in the 3′-CITE and SLII. Nucleotide
substitutions in mutants are shown in red and deleted regions are outlined in green. The nucleotides in the 3′-CITE shown previously to interact with the
translation factor eIF4G are shown in orange (39). Stems in the 3′-CITE are highlighted in yellow and numbered (S4 through S7). Mutants assessed
by in-line probing in (B) are highlighted in blue. The primary stall sites are marked with black arrowheads below the structure. Results are from three
independent experiments, ±SE. (B) In-line probing of svRNA-deficient mutants. The mutants assessed are shown in (A) and are highlighted in blue. In
vitro transcripts of wt and mutant 50-svRNAs were used in the analysis and RNA reactivity for each sample was graphed. Alkaline hydrolysis (–OH)
and T1 nuclease-treated (T1) lanes are shown along with numbering of corresponding G residues. Also shown below the profiles is a schematic depicting
relevant substructures in the RNA and blue dotted lines indicate border locations of the 3′-CITE and SLII. Red asterisks indicate the positions of the
modifications introduced and green asterisks indicate second-site changes in reactivity observed elsewhere in the structure. Independent repeats are shown
in the insets for m20 and wt. Note that peaks in the 3′-CITE region of IL6C are shifted to the left due to the transposition of different numbers of residues
in this mutant.
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Figure 5. Replication of selected svRNA-deficient viral genomic mutants
in protoplasts. (A) Northern blot analysis of selected mutants.Mutants are
listed above the lanes and viral RNA species are labelled on the left. (B)
Graphical representation of relative genome replication and svRNA pro-
duction in (A). Black bars indicate genome replication and grey bars rep-
resent svRNA production. (C) Comparison of in vivo and in vitro svRNA
production. In vivo values are derived from quantitative analysis shown in
(B) and in vitro values were taken from Figure 4. Results are from three
independent experiments, ±SE.
sensitivity (Figure 4A) were introduced into the full-length
infectious clone of TNV-D and tested in protoplast infec-
tions (Figure 5A). Genome accumulation was most severely
affected for IL6C, S6C and m20, containing changes to
the asymmetrical internal loop, S6, or the terminal loop
of SLII, respectively (Figure 5B). Thus, some changes that
inhibit svRNA production in vitro also have major nega-
tive effects on essential viral processes. In contrast, near wt
levels of genome were observed for sr10, m131 and m128
(Figure 5B). However, for these cases, the relative levels of
svRNA observed in vivo were lower than corresponding in
vitro levels (Figure 5C). Such differences may be a conse-
quence of the more complex cellular environment during
infections. Nonetheless, collectively, these results show that
mutants exhibiting notable defects in svRNA production in
in vitro assays also show diminished ability to generate svR-
NAs during infections (Figure 5C).
Functional analyses of svRNA
To gain insights into the possible function(s) of svRNAdur-
ing infections, we assessed the ability of a precursor svRNA
to inhibit viral RNA translation in vitro. We reasoned that
the presence of the 3′-CITE within the svRNA could act
as a sponge for eIF4F, and thus sequester this factor away
from authentic viral RNAs, as was shown previously us-
ing only the TNV-D 3′-CITE as competitor (39). To test
this idea, increasing amounts of svRNA or a size-matched
non-specific (NS) RNA were added to in vitro translation
reactions containing a fixed amount of either genomic or sg
mRNA (Figure 6A–C). In all cases, increases in translation
were observedwith theNS competitor, which is likely due to
it interacting non-specifically with inhibitory factors in the
translation extract. For the viral RNAs, svRNA addition
resulted in dose-dependent inhibition of viral RNA trans-
lation to ∼50%, at the highest level of competitor (Figure
6A–C). In contrast, similar competition assays performed
with two different capped reporter mRNAs and the svRNA
effectively prevented translation at the highest concentra-
tion of svRNA tested (Figure 6D and E). Thus, the svRNA
can compete against both uncapped viral RNAs and capped
mRNA, but is notably more effective at suppressing trans-
lation of the latter.
A second possible function of the svRNA could be to se-
quester Xrn1, if the enzyme stays paused at stall sites for ex-
tended periods of time. For this analysis, an Xrn1-sensitive
non-viral RNA was used as a reporter (Rep). The reaction
also contained either, no added RNA (M), 50-svRNA, a
50-svRNA mutant containing the S6C modification (50-
S6C), or a size-matched NS RNA (Figure 7A). The Rep
RNA was efficiently digested by Xrn1 in the absence of a
competitor RNA. However, although all added competi-
tor RNAs conferred a level of resistance to Xrn1, the wt
viral-based 50-svRNA substrate provided the least protec-
tion when compared to the two controls. Assays were also
conducted with different concentrations of Rep, competitor
RNAs, andXrn1, as well as atmultiple time points, however
similar results to those presented were observed in all cases
(data not shown). Consequently, the findings indicate that
under the conditions tested, the presence of the Xrn1 paus-
ing sequence does not provide added protection from Xrn1
digestion to other RNAs.
A third possible function for the svRNA could be re-
lated to the assembly of viral particles. In this case, the
svRNA could be included as part of the nucleic acid con-
tent of virions. To assess this possibility, we inoculated N.
benthamiana plants with transcripts of wt TNV-D genome
and isolated virus particles from infected leaves. The nu-
cleic acid content of the isolated virus particles was sub-
sequently assessed by northern blotting. This analysis indi-
cated that small amounts of the two viral sgmRNAs, as well
as svRNA, are packaged in TNV-D virus particles (Figure
7B).
Lastly, we wanted to determine if the absence of svRNA
inwhole plant infections would result in a noticeably altered
phenotype. Mutant sr10 was selected for this analysis be-
cause (i) it had near wt levels of infection in protoplasts and
trace levels of svRNA in vitro and in vivo (Figure 4), (ii) its
modification was distal to the upper functionally-relevant
region of the 3′-CITE needed for viral protein translation
(38), (iii) the mutation was away from the terminal loop of
SLII, which is critical for efficient translational readthrough
of p82 (37) and (iv) the substitutions in it did not induce any
noticeable structural changes to other regions in the svRNA
(Figure 4B). N. benthamiana plants were rub-inoculated
with transcripts of wt or sr10 mutant TNV-D genomes. At
6 days post infection, leaves inoculated with wt transcripts
showed leaf curling, yellowing, and necrosis (Figure 7C).
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Figure 6. Translation inhibition assay using TNV-D svRNA as a competitor. (A) In vitro translation with TNV-D genomic RNA. Uncapped in vitro
transcribed wt TNV-D genomic RNA was incubated in wheat germ extract with increasing molar amounts of 50-svRNA or a non-specific (NS) RNA in
the presence of 35S-labelled methionine. Levels of labeled protein were quantified and plotted for the different ratios tested. (B) Competition assay with
sg mRNA1. (C) Competition assay with sg mRNA2. (D and E) Competition assay with capped luciferase and wasabi mRNAs. Results are from three
independent experiments, ±SE.
In contrast, symptoms were markedly attenuated in sr10-
infected leaves, which exhibited patches of small pale le-
sions. The yield of viral RNAs from sr10-infected plants was
∼12% that of the wt infections and, unlike for wt infections,
svRNAs were not detectable and the infection did not move
systemically within plants.
DISCUSSION
We have characterized an svRNA species that is generated
during TNV-D infections. The svRNAs produced using re-
combinant Xrn1 in vitrowere comparable in length to those
generated in infected plant cells, implicating the cytosolic
plant 5′-to-3′exonuclease, Xrn4, as the enzyme generating
svRNAs in vivo. The fact that the svRNAs were generated
with purified Xrn1 also indicates that other host proteins
are not necessary for their production, although the possi-
ble involvement of such factors cannot be precluded.Differ-
ent regions within the major svRNA species were found to
be necessary for its production and distinct structural fea-
tureswithinwere determined to be essential forXrn stalling.
The implications of these and other findings are discussed.
svRNA production from a sg mRNA
Our results indicate that the majority of svRNA produced
during viral infections is generated from sg mRNA1 (Fig-
ure 2D). This RNA is the more abundant of the two sg mR-
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Figure 7. Functional analyses of TNV-D svRNA. (A) Xrn inhibition assay.
A reporter RNA (Rep) was incubated with Xrn1 in the presence of com-
petitors 50-svRNA, 50-S6C, or nonspecific RNA (NS). The amount of re-
maining Rep RNA was quantified by northern blotting. Results are from
three independent experiments, ±SE. (B) Viral RNA analysis of TNV-D
virions. Viral RNA was extracted from virions and analyzed by northern
blotting. RNAs extracted from TNV-infected protoplasts were separated
in the same gel for size comparison. Results from three independent virus
isolations are shown. (C) Infection ofN. benthamiana plants with svRNA-
deficient mutant sr10. Total RNA was extracted from inoculated leaves of
TNV-infected plants six days post infection (dpi), and analyzed by north-
ern blotting. Representative example from three independent experiments
done in triplicate.
NAs transcribed from the TNV-D genome, thus its compar-
atively higher level likely contributes proportionally to the
production of the svRNA (Figure 1A, B). In contrast, al-
though the viral genome accumulates to the greatest relative
level in infections, it contributes minimally to svRNA pro-
duction. This may be due to its efficient packaging, which
could provide protection from RNases (Figure 7B). Con-
versely, neither sg mRNA1 nor 2 is packaged efficiently.
Both RCNMV and BNYVV produce svRNAs from
genomes that also transcribe a standard sg mRNA (28,29),
however the possible contribution of their sg mRNAs to
the production of the svRNAs has not yet been investi-
gated. In BYDV, inactivating sg RNA2 production in infec-
tions reduces accumulation of the svRNA, termed sgRNA3
(48), however it is not known if sgRNA3 is actually gener-
ated by Xrn (22). The possible origin of an svRNA from
a transcribed viral sgRNA has been proposed for the fla-
vivirus Japanese encephalitis virus (JEV) (49). It is well doc-
umented that many flaviviruses produce svRNAs, but these
viruses do not normally transcribe sg mRNAs (11). JEV in-
fections were shown to generate sfRNAs more efficiently in
Xrn1-knockdown cells, suggesting an alternative mode for
their generation. This observation, combined with in vitro
RNA-dependent RNA polymerase promoter activity from
a sequence near the stall site, prompted the notion that in
JEV, sgRNA transcription mediates the production of its
sfRNA (49). Further studies will be required to validate this
atypical transcription-based model for svRNA production
in flaviviruses.
svRNA structure
The RNA structure inhibiting Xrn exoribonucleases in
TNV-D is distinct from other reported structures in terms
of its (i) modularity, (ii) size, and (iii) contiguity. Other
Xrn1-blocking structures have been found to be function-
ally modular (14,29), which contrasts our results with TNV-
D, where adding sequence to the 3′-end of the structure,
which alters its 3′-proximal context, abolished stalling (Fig-
ure 3). This 3′ addition would interfere with formation
of the SLII/3′-terminal sequence interaction involved in
genome replication. This notion is further supported by
the two and three nucleotide deletions of 3′-terminal vi-
ral sequence (mutants –2 and –3) and the SLII bulge dele-
tion (SL2b) that would inhibit this interaction, and all of
which yielded low levels of svRNA (Figure 3A–C). Con-
sequently, these data implicate formation of the SLII/3′-
terminal sequence interaction as an important tertiary-level
stalling determinant. Residues immediately 5′-proximal to
the termination site also influenced stalling function, but
had more modest effects (mutants, sr1 to sr3) (Figure 3C).
The substitutions in this region could potentially alter for-
mation or stability of the downstream blocking structure.
Approximately 5–6 nucleotides are predicted to reside in a
protein channel leading to the active site of Xrn1 (17). In
RCNMV, a sequence just downstream of the stall site is pro-
posed to be involved in the folding of the structure mediat-
ing stalling (30). Specifically, the unwinding of a base-paired
P1 stem immediately downstream of the Xrn1 stop site by
Xrn1 mediates a transition of the structure from an inac-
tive SL to an active pseudoknotted conformation; a process
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/47/17/9329/5545013 by York U
niversity Libraries user on 18 February 2020
9340 Nucleic Acids Research, 2019, Vol. 47, No. 17
termed codegradational remodelling (30). Although alter-
native structures are not predicted for the TNV-D region,
the involvement of possible rearrangements cannot be dis-
counted. Regardless of the mechanism of Xrn interference,
the results suggest that the 5′-context of the blocking struc-
ture does influence processivity, albeit far less than the 3′-
context.
The lack of modularity of the blocking RNA structure in
TNV-Dmay in part relate to its size. Comparable functional
RNA elements reported to date have been substantially
smaller. For example, the linear lengths for the minimal ac-
tive structures for flaviviruses, RCNMV, and BNYVV, are
72–79 nt, 43 nt and 43 nt, respectively (14,29,30). These
sizes are approximately 3- to 5-fold smaller than the linear
length of TNV-D sequence harbouring its stalling structure,
i.e. 212 nt. The atomic structure of the BNYVV RNA ele-
ment is yet to be explored, however those for two flaviviruses
and RCNMV have been solved (15,16). Though distinct in
terms of detailed conformations, all contain pseudoknots
that form ring-like folds around the 5′-ends of the RNA
structures. This unique type of ring structure is predicted
to contact the surface of Xrn1 and act as a brace, causing it
to pause. The compact nature of these RNA elements is in
contrast to the region encompassing the TNV-D stall struc-
ture andmay suggest that a different type of structural com-
plexity is utilized by TNV-D to block Xrn.
Although the linear sequence involved is large, certain re-
gions appear to be more important than others. The abil-
ity to delete the upper portion of the 3′-CITE yet maintain
∼57% activity (mutant Top), rules out a critical role for
this region (Figure 4A), and suggests a non-linear, or non-
contiguous, arrangement of essential components. Three
distinct regionswere determined to bemost critical; i.e. their
modification led to decreases in activity to∼10–15%. These
include the lower region of the 3′-CITE (Figures 3C, 4A),
SLII (Figure 3C, 4A), and the 3′-terminus (Figures 3A-C).
It follows that structural coordination and/or communica-
tion between these elements is required for effective stalling.
As alluded to earlier, base pairing of the SLII bulge with
the 3′-terminal nucleotides is essential for TNV-D genome
replication (37), and this interaction also appears to be im-
portant for formation of an effective stalling RNA struc-
ture. The requirement for specific sequence in the terminal
loop of SLII and corresponding altered chemical reactiv-
ity of the lower region of the 3′-CITE upon its modifica-
tion, along with reciprocal correlative evidence (Figure 4A,
B), suggest an interaction between these two regions. Ad-
ditionally, the hierarchical importance of sequence identity
over base pairing in the lower region of the 3′-CITE (Fig-
ure 3C, and Figure 4A), suggests that non-canonical inter-
actions and/or structural rearrangements may be involved.
The detailed structural relationship between the three key
structural components forming tertiary contacts, as well as
the precise conformational strategy utilized to stall Xrn, re-
main to be elucidated.
Possible svRNA functions
Xrn-generated RNAs represent an emerging area in plant
virology with a small but growing list of examples. Conse-
quently, the functions of these RNAs in plant infections re-
main largely unknown (22). One exception is the svRNA
of BNYVV, which has been demonstrated convincingly to
be required for long-distance movement of the viral infec-
tion in plants (27,28). One can imagine a variety of possible
roles for svRNAs in viral processes related to, for instance,
translation, RNA replication, and/or packaging. The TNV-
D svRNA inhibited translation of both viral and capped
reporter mRNA in trans in wheat germ extract. The corre-
sponding levels of inhibition observed in the dose-response
curves for the three different viral RNAmessages were sim-
ilar (Figure 6A–C), suggesting that all species are supressed
to comparable degrees. In contrast, the svRNA more effi-
ciently competed against capped reporter mRNAs (Figure
6D), suggesting a possible role in preferentially downregu-
lating cellular mRNA levels during infections. The svRNA
of RCNMV was also found to inhibit translation of both
viral reporter mRNAs and capped messages (29). Also, for
the polymerase-generated svRNA of BYDV (24), transla-
tion of the viral genome was inhibited to a greater extent
than sg mRNA1 (50). This latter observation led to the pro-
posal that this svRNA may act as a switch to favor transla-
tion of late genes during infections. A similar regulatory role
in virus translation is not predicted for TNV-D, because all
viral RNAs were supressed to similar levels.
Other possible functions for the TNV-D svRNA could be
to supress Xrn4 activity during infections or facilitate pack-
aging. For TNV-D, our in vitro results did not support a role
for its svRNA in inhibiting Xrn activity (Figure 7A), which
contrasts results from other Xrn1 blocking structures in
mammalian viruses (18,19,51). One could imagine that su-
pressing Xrn4 activity during infections could be beneficial
to the survival of uncapped viral RNA genomes like TNV-
D. The observed lack of inhibitory activity on the enzyme
could be related to the modest level of stalling (∼4.3%),
which probably would not notably affect enzyme turnover.
As for packaging, a small but readily detectable amount of
svRNA was present in virions (Figure 7B). The svRNA of
RCNMV is also packaged into virions, and could mediate
assembly and/or promote particle stability (29). However,
the TNV-D svRNA, and the two sg mRNAs, are not pack-
aged efficiently. Consequently, the incorporation of these 3′-
terminal sg mRNAs and svRNA in virions may be inadver-
tent.
Demonstrating a function for svRNA in plants has
been particularly challenging. Aside from BNYVV (28,29),
in vivo studies of viral genomes, where svRNA produc-
tion has been inactivated, have resulted in only minor ef-
fects (24,29,38). Our testing of an svRNA-deficient TNV-
D mutant in plants showed major differences in symp-
tomology, viral RNA accumulation, and movement (Fig-
ure 7C). Nonetheless, it cannot be precluded that addi-
tional viral processes were affected by the modifications,
even though second-site structural perturbations were not
observed (Figure 4B). Indeed, the structural features that
make the svRNA resistant to Xrn overlap with, or are
highly integrated with, the structural elements important
for a variety of viral processes. Moreover, new functions for
components in this region are being discovered; i.e. the wt
loop sequence of SLII is also required for efficient trans-
lational readthrough (37). It is thus possible that the SLII
loop/lower 3′-CITE interaction needed for Xrn stalling
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is also required for readthrough activity. Further detailed
analyses of these overlapping features will be required to
design mutants that are exclusively deficient in svRNA pro-
duction.
In addition to TNV-D (Betanecrovirus) and RC-
NMV (Dianthovirus), at least three other genera in
family Tombusviridae generate 3′-terminal svRNAs
that likely originate from Xrn4 digestion. These in-
clude, tombusviruses (32), machlomoviruses (34) and
carmoviruses (52). Other genera in this family may also
generate svRNAs, however they may have either been over-
looked or dismissed as nonrelevant degradation products
(22). Recently, a bioinformatics approach was used to iden-
tify additional functional RCNMV-like stalling structures
in umbraviruses (family Tombusviridae), as well as polero-
and enamoviruses (family Luteoviridae) (53). Moreover,
some of the svRNAs identified were predicted to encode
proteins, suggesting that they could function as mRNAs
for viral protein production. Their prevalence in multiple
virus groups and elusive functions make Xrn-resistant
RNAs intriguing subjects for further investigation.
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